Trials / Completed
CompletedNCT02849236
PECS I Block for Breast Subpectoral Implant Surgery
Analgesic Efficacy of the Pectoral Nerve Block Type 1 for Breast Subpectoral Implant Surgery: A Randomized Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Breast augmentation surgery can cause important postoperative pain, especially when bilateral subpectoral implants are used. The investigators hypothesized that a technique of regional analgesia, the pectoral nerve block type I (or "PECS I block") would reduce pain within the first twenty-four hours and, in turn, morphine consumption and associated side effects. This is a randomized, controlled, double-blind study which compares intra and postoperative analgesia with or without PECS I block in breast surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine (PECS bloc) | Ropivacaine 3.75mg/mL Injection of a local anesthetic between pectoral major and pectoral minor muscles |
| DRUG | Placebo | 20 mL saline 0.9% |
Timeline
- Start date
- 2016-10-16
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
- First posted
- 2016-07-29
- Last updated
- 2020-08-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02849236. Inclusion in this directory is not an endorsement.